Press Release
August Allen Named one of the 2017 PM360 Elite 100
For Immediate Release
May 24, 2017
PM360, the premier information resource for marketing decision makers in the pharmaceutical and medical device sectors, has named August Allen, Automation Scientist at Recursion Pharmaceuticals as one of the 2017 PM360 ELITE 100 in the Tech-Know Geeks category. Now in its third year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represents the most influential people in the healthcare industry today.
Allen is a key member of the automation team. One of his first projects at Recursion involved selecting and negotiating an integration project with HighRes Biosolutions for three robotic work cells. The result increased the throughput of their assay by roughly 10 times. As Recursion Pharmaceuticals’ powerful drug discovery platform relies on millions of rapid, automated experiments and analysis to discover new therapeutics, he served as the key force for this new $3 million system.
“We are thrilled that PM360 recognized August Allen as an ELITE winner,” said Chris Gibson, CEO of Recursion Pharmaceuticals. “We are always striving to hire the best and the brightest for our team and August definitely fits that category.”
The PM360 ELITE Awards were established in 2015 to recognize individuals who have made a significant impact to the healthcare industry throughout their careers. More than 500 submissions were received and nominees were evaluated based on their accomplishments; testimonials from their bosses, clients, and colleagues; and supporting evidence that reflects the impact of their efforts. A total of 100 winners were selected across 18 categories, including Creative Directors, Data Miners, Digital Crusaders, Disrupters, Drug Researchers and Developers, Entrepreneurs, Launch Experts, Leaders of the Future, Marketing Teams, Master Educators, Mentors, Patient Advocates, PR Gurus, Sales MVPs, Strategists, Talent Acquisition Leaders, Tech-know Geeks, and Transformational Leaders.
“Each of the 2017 PM360 ELITE 100 demonstrated immense talent in their ability to impact our industry,” says Anna Stashower, CEO and Publisher of PM360. “These people represent the best the industry has to offer, including veterans who have made their mark over and over and up-and-comers who are just getting started.”
Allen and the rest of the winners will be honored at a celebratory event on July 11th in New York City at the rooftop bar 230 FIFTH.
About Recursion Pharmaceuticals
Recursion Pharmaceuticals is an emerging biotechnology company based in Salt Lake City. Recursion combines experimental biology and bioinformatics with artificial intelligence in a massively parallel system to quickly and efficiently identify treatments for any disease which can be modeled at the cellular level. From its initial and continued focus on drug repurposing to treat rare diseases, Recursion has broadened its platform to probe rich data from high-throughput automated screens for a number of indications, including aging, inflammation, infectious disease, oncology, and diagnostics. Recursion’s ultimate vision is to leverage technology to build a robust and reliable map of human cellular biology, which would enable a radical shift in the pace and scale at which new treatments could benefit patients. Learn more at www.recursionpharma.com, or connect on Twitter, Facebook, and LinkedIn.
